Crédit Industriel et Commercial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Crédit Industriel et Commercial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4M	Sell	179,600 -50,000	-22%	-$6.76M	1.83%	11
2026 Q1	$29.3M	Buy	229,600 +40,000	+21%	+$4.99M	2.28%	6
2025 Q4	$23.1M	Buy	189,600 +50,000	+36%	+$5.73M	1.78%	8
2025 Q3	$14M	Hold	139,600	–	–	1.17%	15
2025 Q2	$11.6M	Hold	139,600	–	–	0.99%	25
2025 Q1	$11.3M	Buy	139,600 +89,600	+179%	+$8.01M	1.2%	12
2024 Q4	$4.5M	Buy	+50,000	New	+$4.84M	0.59%	48

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

Crédit Industriel et Commercial's XBI Position: Q2 2026 in Review

Crédit Industriel et Commercial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 67% in Q2 2026, selling an estimated $3.25M and leaving 11,590 shares worth $1.83M. The position accounts for 0.12% of the portfolio, ranked #160.

Crédit Industriel et Commercial first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.55M in Q1 2026. 415 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Crédit Industriel et Commercial held 11,590 shares of State Street SPDR S&P Biotech ETF worth $1.83M as of Q2 2026.
Crédit Industriel et Commercial sold 24,043 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.25M.
State Street SPDR S&P Biotech ETF made up 0.12% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #160 holding.
Crédit Industriel et Commercial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
Crédit Industriel et Commercial's State Street SPDR S&P Biotech ETF position peaked at $4.55M in Q1 2026.
415 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.